MarketCap
Facebook
X
TelegramQuarterly report 2023-Q1
added 05-05-2023
Heska Corporation DIO Ratio 2011-2026 | HSKA
Annual DIO Ratio Heska Corporation
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 137 | 110 | 105 | 142 | 129 | 167 | 97.7 | 97.3 | 85.4 | 89.4 | 109 | 111 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 167 | 85.4 | 115 |
Quarterly DIO Ratio Heska Corporation
| 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 162 | - | 149 | 136 | 134 | - | 112 | 97.6 | 103 | - | 110 | 131 | 177 | - | 138 | 154 | 139 | - | 142 | 138 | 135 | - | 177 | 161 | 148 | - | 94.4 | 108 | 106 | - | 89.4 | 108 | 102 | - | 85.6 | 83.5 | 88.8 | - | 105 | 80.5 | 98.7 | - | 112 | 111 | 111 | - | 105 | 113 | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 177 | 80.5 | 121 |
DIO Ratio of other stocks in the Diagnostics research industry
| Issuer | DIO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Trinity Biotech plc
TRIB
|
212 | $ 0.65 | -1.84 % | $ 61.9 M |  Irlanda |
 |
Centogene N.V.
CNTG
|
25.4 | - | -6.23 % | $ 30.6 M |  Germany |
 |
Agilent Technologies
A
|
97.1 | $ 115.55 | 1.0 % | $ 35.1 B |  USA |
 |
Accelerate Diagnostics
AXDX
|
198 | - | -61.36 % | $ 2.46 M | USA |
 |
Aspira Women's Health
AWH
|
32.2 | - | -6.19 % | $ 10.5 M | USA |
 |
Biocept
BIOC
|
21.9 | - | -13.05 % | $ 7.29 M | USA |
 |
Chembio Diagnostics
CEMI
|
97.6 | - | 0.22 % | $ 16.8 M | USA |
 |
Co-Diagnostics
CODX
|
1.69 K | $ 1.67 | -2.34 % | $ 2.22 M | USA |
 |
Castle Biosciences
CSTL
|
48.7 | $ 24.46 | 3.25 % | $ 679 M | USA |
 |
CareDx, Inc
CDNA
|
48.3 | $ 21.23 | 5.83 % | $ 1.13 B | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
210 | - | - | $ 562 M |  Britain |
 |
DermTech
DMTK
|
33.5 | - | -11.32 % | $ 2.94 M | USA |
 |
Lantheus Holdings
LNTH
|
40.4 | $ 84.33 | 1.82 % | $ 5.69 B | USA |
 |
Enzo Biochem
ENZ
|
156 | - | -8.98 % | $ 14.8 K | USA |
 |
Exact Sciences Corporation
EXAS
|
60.9 | - | - | $ 19.8 B | USA |
 |
Fulgent Genetics
FLGT
|
7.17 | $ 16.31 | 1.75 % | $ 493 M | USA |
 |
Global Cord Blood Corporation
CO
|
89.7 | - | - | $ 399 M |  China |
 |
Fluidigm Corporation
FLDM
|
131 | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
42.1 | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
62.8 | - | 0.12 % | $ 80.1 M | China |
 |
Charles River Laboratories International
CRL
|
35.3 | $ 169.8 | 1.23 % | $ 8.42 B | USA |
 |
Guardant Health
GH
|
82.1 | $ 88.91 | 1.18 % | $ 11.1 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
116 | - | -20.0 % | $ 1.06 M | USA |
 |
Interpace Biosciences
IDXG
|
29.1 | $ 1.98 | -2.37 % | $ 8.76 M | USA |
 |
Illumina
ILMN
|
137 | $ 127.88 | 1.95 % | $ 20.3 B | USA |
 |
Koninklijke Philips N.V.
PHG
|
89 | $ 27.47 | -0.58 % | $ 20 B |  Niderland |
 |
Personalis
PSNL
|
12.1 | $ 6.1 | 3.39 % | $ 361 M | USA |
 |
QIAGEN N.V.
QGEN
|
141 | - | - | $ 10.6 B | Niderland |
 |
Biomerica
BMRA
|
147 | $ 2.14 | -0.47 % | $ 4.92 M | USA |
 |
ICON Public Limited Company
ICLR
|
0.213 | $ 102.17 | -3.92 % | $ 8.43 B | Irlanda |
 |
Laboratory Corporation of America Holdings
LH
|
18.9 | $ 263.8 | -0.43 % | $ 21.9 B | USA |
 |
Motus GI Holdings
MOTS
|
3.37 K | - | -34.28 % | $ 263 K |  Israel |
 |
Thermo Fisher Scientific
TMO
|
86.5 | $ 469.71 | 0.64 % | $ 177 B | USA |
 |
NeoGenomics
NEO
|
24.4 | $ 8.29 | 4.8 % | $ 1.06 B | USA |
 |
Neogen Corporation
NEOG
|
147 | $ 9.54 | 2.03 % | $ 2.07 B | USA |
 |
Twist Bioscience Corporation
TWST
|
51.5 | $ 60.94 | 3.55 % | $ 3.64 B | USA |
 |
Myriad Genetics
MYGN
|
42.8 | $ 4.78 | -0.21 % | $ 443 M | USA |
 |
Natera
NTRA
|
25.8 | $ 203.75 | 1.3 % | $ 20.1 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
9.34 | $ 196.27 | -1.66 % | $ 21.8 B | USA |
 |
Invitae Corporation
NVTA
|
126 | - | - | $ 21.2 M | USA |
 |
Organovo Holdings
ONVO
|
371 | - | -2.3 % | $ 19.4 M | USA |
 |
OpGen
OPGN
|
459 | - | -16.95 % | $ 1.54 M | USA |
 |
Waters Corporation
WAT
|
528 | $ 309.87 | -0.43 % | $ 18.5 B | USA |